Description of Case of Infection With a New Species of Babesia and Its Molecular Diagnosis
NCT ID: NCT04960995
Last Updated: 2021-07-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
1 participants
OBSERVATIONAL
2021-07-10
2021-07-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Human Babesiosis in Metropolitan France
NCT07345988
Study of Febrile Syndromes After Tick Bite
NCT05090969
Human Anaplasmosis in Eastern France
NCT01013636
Epidemiological, Clinical and Biological Characteristics of Human Anaplasmosis Cases in Alsace
NCT07312474
Surveillance of Emerging Pathogens to Ensure Blood Supply Safety
NCT06462677
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
RETROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Splenectomized subject
* Subject with severe babesiosis
* Subject not having expressed, after information, his opposition to the reuse of his data for the purposes of this research
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Strasbourg, France
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Alexander PFAFF, MCU-PH
Role: PRINCIPAL_INVESTIGATOR
Parasitology and Medical Mycology Department - Strasbourg University Hospitals
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Parasitology and Medical Mycology Department - Strasbourg University Hospitals
Strasbourg, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
8341
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.